ClinicalTrials.Veeva

Menu

Initiation of Noninvasive Ventilation in ALS Patients With Chronic Respiratory Insufficiency (InNIVALS)

T

Tampere University

Status

Enrolling

Conditions

Chronic Respiratory Failure
ALS
Ventilation Therapy

Treatments

Other: NIV initiation in patients with ALS

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

This research will study whether noninvasive ventilation (NIV) used to treat chronic respiratory insufficiency in patients with amyotrophic lateral sclerosis (ALS) can be initiated as successfully in the outpatient setting as in the conventional inpatient setting, and what the costs of these alternative initiation methods are.

Enrollment

120 estimated patients

Sex

All

Ages

18 to 99 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • ALS diagnosed by a neurology and
  • chronic respiratory insufficiency or significant respiratory muscle weakness caused by ALS

Exclusion criteria

  • impaired cognition to give informed consent to participation
  • contraindication to NIV therapy
  • another severe disease with a prognosis of less than one year
  • ventilation via an artificial airway, tracheostomy

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

120 participants in 2 patient groups

NIV initiation in outpatient clinic in patients with ALS
Active Comparator group
Description:
Starting the NIV at the outpatient clinic
Treatment:
Other: NIV initiation in patients with ALS
NIV initiation in pulmonary ward in patients with ALS
Active Comparator group
Description:
Starting the NIV in the pulmonary ward
Treatment:
Other: NIV initiation in patients with ALS

Trial contacts and locations

1

Loading...

Central trial contact

Hanna Korkeamäki, MD, MSc; Heidi A Rantala, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems